HC Wainwright Reiterates Buy Rating on Eton Pharmaceuticals
HC Wainwright & Co. reiterated its Buy rating and $70 price target on Eton Pharmaceuticals. The target implies 31.3% upside from the Oct. 13 close of $53.33.
HC Wainwright & Co. reiterated its Buy rating and $70 price target on Eton Pharmaceuticals. The target implies 31.3% upside from the Oct. 13 close of $53.33.